Menu
Back to Journals » Vascular Health and Risk Management » Volume 9 » default
Vascular Health and Risk Management
ISSN: 1178-2048
- View all (1489)
- Volume 19, 2023 (79)
- Volume 18, 2022 (87)
- Volume 17, 2021 (80)
- Volume 16, 2020 (60)
- Volume 15, 2019 (54)
- Volume 14, 2018 (42)
- Volume 13, 2017 (54)
- Volume 12, 2016 (52)
- Volume 11, 2015 (66)
- Volume 10, 2014 (74)
- Volume 9, 2013 (73)
- Volume 8, 2012 (74)
- Volume 7, 2011 (92)
- Volume 6, 2010 (113)
- Volume 5, 2009 (112)
- Volume 4, 2008 (164)
- Volume 3, 2007 (113)
- Volume 2, 2006 (57)
- Volume 1, 2005 (43)
Archive: Volume 9, 2013
Serum lipid profile and correlates in newly presenting Nigerians with arterial hypertension
Adamu UG, Okuku GA, Oladele CO, Abdullahi A, Oduh JI, Fasae AJ
Vascular Health and Risk Management 2013, 9:763-768
Published Date: 3 December 2013
Vitamin E tocotrienol supplementation improves lipid profiles in chronic hemodialysis patients
Daud ZAM, Tubie B, Sheyman M, Osia R, Adams J, Tubie S, Khosla P
Vascular Health and Risk Management 2013, 9:747-761
Published Date: 28 November 2013
Visceral obesity is not an independent risk factor of mortality in subjects over 65 years
Thomas F, Pannier B, Benetos A, Vischer UM
Vascular Health and Risk Management 2013, 9:739-745
Published Date: 22 November 2013
Vitamin D deficiency is associated with development of subclinical coronary artery disease in HIV-infected African American cocaine users with low Framingham-defined cardiovascular risk
Lai H, Fishman EK, Gerstenblith G, Moore R, Brinker JA, Keruly JC, Chen S, Detrick B, Lai S
Vascular Health and Risk Management 2013, 9:729-737
Published Date: 15 November 2013
Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy
Foody JM, Toth PP, Tomassini JE, Sajjan S, Ramey DR, Neff D, Tershakovec AM, Hu H, Tunceli K
Vascular Health and Risk Management 2013, 9:719-727
Published Date: 15 November 2013
Efficacy and safety of insulin glargine added to a fixed-dose combination of metformin and a dipeptidyl peptidase-4 inhibitor: results of the GOLD observational study
Seufert J, Pegelow K, Bramlage P
Vascular Health and Risk Management 2013, 9:711-717
Published Date: 13 November 2013
Lipid profiles and inflammatory markers after periodontal treatment in children with congenital heart disease and at risk for atherosclerosis
Bresolin AC, Pronsatti MM, Pasqualotto LN, Nassar PO, Jorge AS, Silva EA, Nassar CA
Vascular Health and Risk Management 2013, 9:703-709
Published Date: 11 November 2013
Titration of amlodipine to higher doses: a comparison of Asian and Western experience
Kario K, Robbins J, Jeffers BW
Vascular Health and Risk Management 2013, 9:695-701
Published Date: 5 November 2013
Linagliptin as add-on therapy to insulin for patients with type 2 diabetes
von Websky K, Reichetzeder C, Hocher B
Vascular Health and Risk Management 2013, 9:681-694
Published Date: 1 November 2013
Association between triglycerides and cardiovascular events in primary populations: a meta-regression analysis and synthesis of evidence
Stauffer ME, Weisenfluh L, Morrison A
Vascular Health and Risk Management 2013, 9:671-680
Published Date: 31 October 2013
Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes
Kones R
Vascular Health and Risk Management 2013, 9:617-670
Published Date: 21 October 2013
Cardiovascular outcomes during treatment with dabigatran: comprehensive analysis of individual subject data by treatment
Clemens A, Fraessdorf M, Friedman J
Vascular Health and Risk Management 2013, 9:599-615
Published Date: 11 October 2013
Postmarketing safety experience with edoxaban in Japan for thromboprophylaxis following major orthopedic surgery
Kuroda Y, Hirayama C, Hotoda H, Nishikawa Y, Nishiwaki A
Vascular Health and Risk Management 2013, 9:593-598
Published Date: 7 October 2013
Comprehensive overview: efficacy, tolerability, and cost-effectiveness of irbesartan
Gialama F, Maniadakis N
Vascular Health and Risk Management 2013, 9:575-592
Published Date: 7 October 2013
Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation: the ECLIPSE II study
Offman E, Marenco T, Ferber S, Johnson J, Kling D, Curcio D, Davidson M
Vascular Health and Risk Management 2013, 9:563-573
Published Date: 1 October 2013
Lifetime opiate exposure as an independent and interactive cardiovascular risk factor in males: a cross-sectional clinical study
Reece AS, Hulse GK
Vascular Health and Risk Management 2013, 9:551-561
Published Date: 2 October 2013
Comparative effectiveness of a fixed-dose combination of losartan + HCTZ versus bisoprolol + HCTZ in patients with moderate-to-severe hypertension: results of the 6-month ELIZA trial
Radchenko GD, Sirenko YM, Kushnir SM, Torbas OO, Dobrokhod AS
Vascular Health and Risk Management 2013, 9:535-549
Published Date: 27 September 2013
Left ventricular dysfunction in normotensive type II diabetic patients in Port Harcourt, Nigeria
Dodiyi-Manuel ST, Akpa MR, Odia OJ
Vascular Health and Risk Management 2013, 9:529-533
Published Date: 25 September 2013
A review of the benefits of early treatment initiation with single-pill combinations of telmisartan with amlodipine or hydrochlorothiazide
Segura J, Ruilope LM
Vascular Health and Risk Management 2013, 9:521-528
Published Date: 16 September 2013
Serum calcium levels are not associated with coronary heart disease
Jin Y, He L, Wang Q, Chen Y, Ren X, Tang H, Song X, Ding L, Qi Q, Huang Z, Yu J, Yao Y
Vascular Health and Risk Management 2013, 9:517-520
Published Date: 3 September 2013
Increased burden and severity of metabolic syndrome and arterial stiffness in treatment naïve HIV+ patients from Cameroon
Ngatchou W, Lemogoum D, Ndobo P, Yagnigni E, Tiogou E, Nga E, Kouanfack C, van de Borne P, Hermans MP
Vascular Health and Risk Management 2013, 9:509-516
Published Date: 4 September 2013
Spanish translation, cross-cultural adaptation, and validation of the Questionnaire for Diabetes-Related Foot Disease (Q-DFD)
Castillo-Tandazo W, Flores-Fortty A, Feraud L, Tettamanti D
Vascular Health and Risk Management 2013, 9:501-508
Published Date: 28 August 2013
Vitamin D deficiency is associated with coronary artery calcification in cardiovascularly asymptomatic African Americans with HIV infection
Lai S, Fishman EK, Gerstenblith G, Brinker J, Tai H, Chen S, Li J, Tong W, Detrick B, Lai H
Vascular Health and Risk Management 2013, 9:493-500
Published Date: 26 August 2013
Perceptions of barriers to cardiac rehabilitation use in Brazil
Ghisi GLM, Santos RZ, Aranha EE, Nunes AD, Oh P, Benetti M, Grace SL
Vascular Health and Risk Management 2013, 9:485-491
Published Date: 30 August 2013
Safety, tolerability, and efficacy of a fixed-dose combination of olmesartan 40 mg and hydrochlorothiazide 12.5/25 mg in daily practice
Bramlage P, Zemmrich C, Ketelhut R, Wolf WP, Fronk EM, Schmieder RE
Vascular Health and Risk Management 2013, 9:475-483
Published Date: 26 August 2013
Prognostic value of heart rate turbulence for risk assessment in patients with unstable angina and non-ST elevation myocardial infarction
Harris PRE, Stein PK, Fung GL, Drew BJ
Vascular Health and Risk Management 2013, 9:465-473
Published Date: 12 August 2013
Vacuum-venipuncture skills: time required and importance of tube order
Fujii C
Vascular Health and Risk Management 2013, 9:457-464
Published Date: 5 August 2013
Emerging families of biomarkers for coronary artery disease: inflammatory mediators
Yayan J
Vascular Health and Risk Management 2013, 9:435-456
Published Date: 31 July 2013
Use of pioglitazone in the treatment of diabetes: effect on cardiovascular risk
Zou C, Hu H
Vascular Health and Risk Management 2013, 9:429-433
Published Date: 25 July 2013
Current status of NADPH oxidase research in cardiovascular pharmacology
Rodiño-Janeiro BK, Paradela-Dobarro B, Castiñeiras-Landeira MI, Raposeiras-Roubín S, González-Juanatey JR, Álvarez E
Vascular Health and Risk Management 2013, 9:401-428
Published Date: 25 July 2013
The COSEHC™ Global Vascular Risk Management quality improvement program: first follow-up report
Ferrario CM, Joyner J, Colby C, Exuzides A, Moore M, Simmons D, Bestermann Jr W, Frech-Tamas F
Vascular Health and Risk Management 2013, 9:391-400
Published Date: 22 July 2013
Clarification of the characteristics of needle-tip movement during vacuum venipuncture to improve safety
Fujii C
Vascular Health and Risk Management 2013, 9:381-390
Published Date: 23 July 2013
Effects of low-fat dairy intake on blood pressure, endothelial function, and lipoprotein lipids in subjects with prehypertension or stage 1 hypertension
Maki KC, Rains TM, Schild AL, Dicklin MR, Park KM, Lawless AL, Kelley KM
Vascular Health and Risk Management 2013, 9:369-379
Published Date: 23 July 2013
Neutrophil/lymphocyte ratio in patients with atrial septal aneurysm
Demir M, Demir C
Vascular Health and Risk Management 2013, 9:365-368
Published Date: 19 July 2013
Hyperhomocysteinemia and vascular access thrombosis in hemodialysis patients: a retrospective study
Saifan C, El-Charabaty E, El-Sayegh S
Vascular Health and Risk Management 2013, 9:361-364
Published Date: 17 July 2013
Review and recommendations on management of refractory raised intracranial pressure in aneurysmal subarachnoid hemorrhage
Mak CH, Lu YY, Wong GK
Vascular Health and Risk Management 2013, 9:353-359
Published Date: 11 July 2013
The clinical efficacy of dabigatran etexilate for preventing stroke in atrial fibrillation patients
Ellis CR, Kaiser DW
Vascular Health and Risk Management 2013, 9:341-352
Published Date: 9 July 2013
Pattern of sudden death at Ladoke Akintola University of Technology Teaching Hospital, Osogbo, South West Nigeria
Akinwusi PO, Komolafe AO, Olayemi OO, Adeomi AA
Vascular Health and Risk Management 2013, 9:333-339
Published Date: 24 June 2013
Aldosterone receptor antagonists: current perspectives and therapies
Guichard JL, Clark III D, Calhoun DA, Ahmed MI
Vascular Health and Risk Management 2013, 9:321-331
Published Date: 24 June 2013
Statins in heart failure: do we need another trial?
Bonsu KO, Kadirvelu A, Reidpath DD
Vascular Health and Risk Management 2013, 9:303-319
Published Date: 17 June 2013
Persistent middle cerebral artery occlusion associated with lower body temperature on admission
Kvistad CE, Øygarden H, Thomassen L, Waje-Andreassen U, Naess H
Vascular Health and Risk Management 2013, 9:297-302
Published Date: 17 June 2013
Evaluation of vascular wall elasticity of human digital arteries using alternating current-signal photoplethysmography
Uangpairoj P, Shibata M
Vascular Health and Risk Management 2013, 9:283-295
Published Date: 5 June 2013
Management of dyslipidemia and hyperglycemia with a fixed-dose combination of sitagliptin and simvastatin
Steinberg H, Anderson MS, Musliner T, Hanson ME, Engel SS
Vascular Health and Risk Management 2013, 9:273-282
Published Date: 29 May 2013
Validation of Omron RS8, RS6, and RS3 home blood pressure monitoring devices, in accordance with the European Society of Hypertension International Protocol revision 2010
Takahashi H, Yoshika M, Yokoi T
Vascular Health and Risk Management 2013, 9:265-272
Published Date: 28 May 2013
Current and future initiatives for vascular health management in clinical practice
Cameron JD, Asmar R, Struijker-Boudier H, Shirai K, Sirenko Y, Kotovskaya Y, Topouchian J
Vascular Health and Risk Management 2013, 9:255-264
Published Date: 28 May 2013
Esomeprazole and aspirin fixed combination for the prevention of cardiovascular events
Sylvester KW, Cheng JW, Mehra MR
Vascular Health and Risk Management 2013, 9:245-254
Published Date: 16 May 2013
Red blood cell count as an indicator of microvascular complications in Chinese patients with type 2 diabetes mellitus
Wang ZS, Song ZC, Bai JH, Li F, Wu T, Qi J, Hu J
Vascular Health and Risk Management 2013, 9:237-243
Published Date: 14 May 2013
Effects of CPAP on "vascular" risk factors in patients with obstructive sleep apnea and arterial hypertension
Litvin AY, Sukmarova ZN, Elfimova EM, Aksenova AV, Galitsin PV, Rogoza AN, Chazova IE
Vascular Health and Risk Management 2013, 9:229-235
Published Date: 10 May 2013
Potential role of new anticoagulants for prevention and treatment of venous thromboembolism in cancer patients
Gómez-Outes A, Suárez-Gea ML, Lecumberri R, Terleira-Fernández AI, Vargas-Castrillón E, Rocha E
Vascular Health and Risk Management 2013, 9:207-228
Published Date: 8 May 2013
Endoglin: a critical mediator of cardiovascular health
Kapur NK, Morine KJ, Letarte M
Vascular Health and Risk Management 2013, 9:195-206
Published Date: 6 May 2013
Platelet function testing to predict hyporesponsiveness to clopidogrel in patients with chest pain seen in the emergency department
Sharma RK, Erickson SW, Sharma R, Voelker DJ, Reddy HK, Dod H, Marsh JD
Vascular Health and Risk Management 2013, 9:187-193
Published Date: 1 May 2013
Awareness, treatment, and control of major cardiovascular risk factors in a small-scale Italian community: results of a screening campaign
Omboni S, Carabelli G, Ghirardi E, Carugo S
Vascular Health and Risk Management 2013, 9:177-185
Published Date: 30 April 2013
Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update
Tsuji Y, Dobrev D
Vascular Health and Risk Management 2013, 9:165-175
Published Date: 23 April 2013
Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes
Ahrén B
Vascular Health and Risk Management 2013, 9:155-163
Published Date: 24 April 2013
Stress-induced cardiomyopathy (Takotsubo) – broken heart and mind?
Redfors B, Shao Y, Omerovic E
Vascular Health and Risk Management 2013, 9:149-154
Published Date: 17 April 2013
Short-term outcome of patients with preeclampsia
Koual M, Abbou H, Carbonnel M, Picone O, Ayoubi JM
Vascular Health and Risk Management 2013, 9:143-148
Published Date: 15 April 2013
Long-term safety and efficacy of endovascular abdominal aortic aneurysm repair
Propper BW, Abularrage CJ
Vascular Health and Risk Management 2013, 9:135-141
Published Date: 3 April 2013
Antihypertensive therapy: nocturnal dippers and nondippers. Do we treat them differently?
Mahabala C, Kamath P, Bhaskaran U, Pai ND, Pai AU
Vascular Health and Risk Management 2013, 9:125-133
Published Date: 24 March 2013
Hydrogen sulfide and sodium nitroprusside compete to activate/deactivate MMPs in bone tissue homogenates
Vacek TP, Qipshidze N, Tyagi SC
Vascular Health and Risk Management 2013, 9:117-123
Published Date: 19 March 2013
The influence of perivascular adipose tissue on vascular homeostasis
Szasz T, Bomfim GF, Webb RC
Vascular Health and Risk Management 2013, 9:105-116
Published Date: 28 March 2013
Long-term safety and efficacy of telmisartan/amlodipine single pill combination in the treatment of hypertension
Billecke SS, Marcovitz PA
Vascular Health and Risk Management 2013, 9:95-104
Published Date: 16 March 2013
Comparison between oscillometric- and Doppler-ABI in elderly individuals
Takahashi I, Furukawa K, Ohishi W, Takahashi T, Matsumoto M, Fujiwara S
Vascular Health and Risk Management 2013, 9:89-94
Published Date: 8 March 2013
Adverse drug events associated with vitamin K antagonists: factors of therapeutic imbalance
El-Helou N, Al-Hajje A, Ajrouche R, Awada S, Rachidi S, Zein S, Salameh P
Vascular Health and Risk Management 2013, 9:81-88
Published Date: 1 March 2013
Lipid management in 13,000 high risk cardiovascular patients treated under daily practice conditions: LIMA Registry
Schaefer JR, Gitt AK, Sonntag F, Weizel A, Jannowitz C, Karmann B, Pittrow D, Bestehorn K
Vascular Health and Risk Management 2013, 9:71-80
Published Date: 21 February 2013
Comparative effect of clopidogrel plus aspirin and aspirin monotherapy on hematological parameters using propensity score matching
Hayasaka M, Takahashi Y, Nishida Y, Yoshida Y, Hidaka S, Asai S
Vascular Health and Risk Management 2013, 9:65-70
Published Date: 18 February 2013
Clinical evidence and mechanistic basis for vildagliptin's effect in combination with insulin
Schweizer A, Foley JE, Kothny W, Ahrén B
Vascular Health and Risk Management 2013, 9:57-64
Published Date: 15 February 2013
Cardioprotective medication use and risk factor control among US adults with unrecognized myocardial infarction: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study
Levitan EB, Gamboa C, Safford MM, Rizk DV, Brown TM, Soliman EZ, Muntner P
Vascular Health and Risk Management 2013, 9:47-55
Published Date: 5 February 2013
Metabolic biomarkers for predicting cardiovascular disease
Montgomery JE, Brown JR
Vascular Health and Risk Management 2013, 9:37-45
Published Date: 29 January 2013
Heel-rise test in the assessment of individuals with peripheral arterial occlusive disease
Monteiro DP, Britto RR, Lages AC, Basílio ML, Pires MC, Carvalho ML, Procópio RJ, Pereira DA
Vascular Health and Risk Management 2013, 9:29-35
Published Date: 23 January 2013
Efficacy of vildagliptin in combination with insulin in patients with type 2 diabetes and severe renal impairment
Lukashevich V, Schweizer A, Foley JE, Dickinson S, Groop PH, Kothny W
Vascular Health and Risk Management 2013, 9:21-28
Published Date: 23 January 2013
Effectiveness of a quality improvement intervention targeting cardiovascular risk factors: are patients responsive to information and encouragement by mail or post?
Senesael E, Borgermans L, Van De Vijver E, Devroey D
Vascular Health and Risk Management 2013, 9:13-20
Published Date: 13 February 2013
Atrial fibrillation and thromboprophylaxis in heart failure: the need for patient-centered approaches to address adherence
Ferguson C, Inglis SC, Newton PJ, Middleton S, Macdonald PS, Davidson PM
Vascular Health and Risk Management 2013, 9:3-11
Published Date: 17 January 2013
Corrigendum
Basit A, Riaz M, Fawwad A
Vascular Health and Risk Management 2013, 9:1-2
Published Date: 27 December 2012